Iofina (LON:IOF – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Canaccord Genuity Group in a report released on Friday, October 16th, Digital Look reports. They currently have a GBX 70 target price on the stock. Canaccord Genuity Group‘s price target points to a potential upside of 46.14% from the stock’s previous close.
Iofina Trading Down 2.2%
Shares of LON:IOF traded down GBX 1.10 during trading on Friday, reaching GBX 47.90. 336,995 shares of the company were exchanged, compared to its average volume of 528,638. The firm has a market capitalization of £91.90 million, a PE ratio of 10.64 and a beta of 0.96. The business’s fifty day simple moving average is GBX 52.41 and its 200-day simple moving average is GBX 49.16. Iofina has a 12-month low of GBX 20 and a 12-month high of GBX 60.12. The company has a debt-to-equity ratio of 10.80, a current ratio of 2.57 and a quick ratio of 1.56.
Iofina (LON:IOF – Get Free Report) last posted its quarterly earnings results on Monday, September 21st. The company reported GBX 1.80 earnings per share for the quarter. Iofina had a net margin of 12.91% and a return on equity of 15.30%. On average, research analysts anticipate that Iofina will post 1.82 EPS for the current year.
About Iofina
Iofina plc is a vertically integrated company that specialises in the production of Iodine and the manufacturing of specialty chemical products and derivatives. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities, Iofina Resources, and Iofina Chemical.
Featured Stories
- Five stocks we like better than Iofina
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for Iofina Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iofina and related companies with MarketBeat.com's FREE daily email newsletter.
